← Back to news

N

NYT Business RSS Feed

Social Security Announces a 2.8% Cost-of-Living Increase for Beneficiaries

Comparing Savings Accounts and CDs Before the Fed Looks at a Possible Rate Cut

Bonds Should Be Boring. But They’ve Been on a Roller Coaster.

The Wider Costs of the N.B.A. Insider-Trading Scandal

Data showing a resilient economy largely reflect spending by the rich.

U.S. Inflation Edged Higher in September as Fed Prepares to Cut Rates Again

Companies Have Shielded Buyers From Tariffs. But Not for Long.

AWS Cloud-Computing Outage Left Smart Bed Customers Without Sleep

Inflation Edged Higher in September as Fed Prepares to Cut Rates Again

Hollywood Weeps as Warner Bros. Hangs a Sale Sign

With ‘Vibecoding,’ A.I. Can Help Anyone Build an App

2025 Halloween Candy Trends

India’s Most Valuable Export: Tens of Millions of Workers

Trump Says He’s Cutting Off Trade Negotiations With Canada

Target to Cut 1,800 Corporate Jobs in Efficiency Drive

Musk Attacks NASA Leader Over Threat to Reconsider Lunar Contract

G. Michael Brown, Who Regulated and Then Ran Casinos, Dies at 82

Ford’s Profit Jumps on Strong Sales but Company Lowers its Outlook

Trump’s Sanctions on Russian Oil Sector Ratchet Up Economic War

Trump Opens ANWR to Oil Drilling

Cattle Ranchers are Furious About Trump’s Plan to Import More Argentine Beef

Democrats Block Federal Worker Pay Bill as Shutdown Drags On

U.S. to Investigate China’s Compliance With 2020 Trade Deal

Volkswagen Says Loss of Chip Supply Could Hit Production

U.S. Health Workers Recalled From Shutdown Furlough for Medicare, A.C.A. Enrollments

Trump Pardons Changpeng Zhao, Founder of the Crypto Exchange Binance

U.S. Sanctions on Russian Oil Could Push India to Stop Buying It

Musk’s Trillion-Dollar Pitch

Oil Price Jumps on Trump’s Russia Sanctions

Broadway Averts Strike as Musicians Reach Deal With Producers

Putin Calls U.S. Sanctions ‘Unfriendly Act’ and Says Russia Won’t Bend

How Federal Workers Can Find Financial Assistance as Government Shutdown Drags On

Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices